1. Home
  2. FONR vs SERA Comparison

FONR vs SERA Comparison

Compare FONR & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fonar Corporation

FONR

Fonar Corporation

HOLD

Current Price

$18.69

Market Cap

116.9M

Sector

Health Care

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$3.56

Market Cap

134.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FONR
SERA
Founded
1978
2008
Country
United States
United States
Employees
N/A
64
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.9M
134.3M
IPO Year
1987
2021

Fundamental Metrics

Financial Performance
Metric
FONR
SERA
Price
$18.69
$3.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
149.7K
66.5K
Earning Date
02-17-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.08
N/A
Revenue
$105,434,318.00
$95,000.00
Revenue This Year
N/A
$25.84
Revenue Next Year
N/A
$715.79
P/E Ratio
$17.27
N/A
Revenue Growth
3.36
1.06
52 Week Low
$12.00
$1.37
52 Week High
$18.86
$6.92

Technical Indicators

Market Signals
Indicator
FONR
SERA
Relative Strength Index (RSI) 80.23 55.57
Support Level $18.50 $3.30
Resistance Level $18.67 $3.85
Average True Range (ATR) 0.06 0.25
MACD -0.01 0.02
Stochastic Oscillator 74.51 72.38

Price Performance

Historical Comparison
FONR
SERA

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: